Promoter analysis and chromosomal mapping of human EBAG9 gene

Biochemical and Biophysical Research Communications

Volumn 273, Issue 2, 2000, Pages 654-660

  Ikeda, Kazuhiro ^a   Sato, Masako ^a   Tsutsumi, Osamu ^c,d   Tsuchiya, Fujiko ^a   Tsuneizumi, Michiko ^b   Emi, Mitsuru ^b   Imoto, Issei ^e   Inazawa, Johji ^e   Muramatsu, Masami ^a   Inoue, Satoshi ^a,d  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^e TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cancer; EBAG9; Estrogen; Estrogen receptor; Estrogen responsive element; FISH; Transcriptional regulation

Indexed keywords

ESTROGEN; ESTROGEN RECEPTOR; LUCIFERASE; MEMBRANE ANTIGEN; TUMOR ANTIGEN;

ARTICLE; BINDING SITE; CARCINOGENESIS; CELL STRAIN MCF 7; CHROMOSOME 8Q; CONTROLLED STUDY; CPG ISLAND; DELETION MUTANT; DNA FLANKING REGION; ELECTROPHORETIC MOBILITY; ESTROGEN ACTIVITY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE MAPPING; HORMONE DEPENDENCE; HUMAN; HUMAN CELL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; SEQUENCE HOMOLOGY; TATA BOX; TRANSCRIPTION INITIATION;

MINK CELL FOCUS-FORMING VIRUS;

EID: 0033885954     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2920     Document Type: Article

References (24)

1. Couse J. F., Korach K. S. Estrogen receptor null mice: what have we learned and where will they lead us? Endocr. Rev. 20:1999;358-417.
2. Prall O. W., Rogan E. M., Sutherland R. L. Estrogen regulation of cell cycle progression in breast cancer cells. J. Steroid. Biochem. Mol. Biol. 65:1998;169-174.
3. Hulka B. S., Liu E. T., Lininger R. A. Steroid hormones and risk of breast cancer. Cancer. 74:1994;1111-1124.
4. Nilsson S., Kuiper G., Gustafsson J. A. ERβ a novel estrogen receptor offers the potential for new drug development. Trends Endocrinol. Metab. 9:1998;387-395.
5. Henderson B. E., Feigelson H. S. Hormonal carcinogenesis. Carcinogenesis. 21:2000;427-433.
6. Watanabe T., Inoue S., Hiroi H., Orimo A., Kawashima H., Muramatsu M. Isolation of estrogen-responsive genes with a CpG island library. Mol. Cell. Biol. 18:1998;442-449.
7. Nakashima M., Sonoda K., Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat. Med. 5:1999;938-942.
8. Sonoda K., Nakashima M., Kaku T., Kamura T., Nakano H., Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer. 77:1996;1501-1509.
9. Kaku T., Sonoda K., Kamura T., Hirakawa T., Sakai K., Amada S., Ogawa S., Kobayashi H., Nakashima M., Watanabe T., Nakano H. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin. Cancer Res. 5:1999;1449-1453.
10. Mukae N., Enari M., Sakahira H., Fukuda Y., Inazawa J., Toh H., Nagata S. Molecular cloning and characterization of human caspase-activated DNase. Proc. Natl. Acad. Sci. USA. 95:1998;9123-9128.
11. Ikeda K., Orimo A., Higashi Y., Muramatsu M., Inoue S. Efp as a primary estrogen-responsive gene in human breast cancer. FEBS Lett. 472:2000;9-13.
12. Graham F. L., van der Eb A. J. A new technique for the assay of infectivity of human adenovirus 5 DNA. Virology. 52:1973;456-467.
13. Inoue S., Orimo A., Hosoi T., Kondo S., Toyoshima H., Kondo T., Ikegami A., Ouchi Y., Orimo H., Muramatsu M. Genomic binding-site cloning reveals an estrogen-responsive gene that encodes a RING finger protein. Proc. Natl. Acad. Sci. USA. 90:1993;11117-11121.
14. Ikeda K., Inoue S., Orimo A., Sano M., Watanabe T., Tsutsumi K., Muramatsu M. Multiple regulatory elements and binding proteins of the 5′-flanking region of the human estrogen-responsive finger protein (efp) gene. Biochem. Biophys. Res. Commun. 236:1997;765-771.
15. Hiroi H., Inoue S., Watanabe T., Goto W., Orimo A., Momoeda M., Tsutsumi O., Taketani Y., Muramatsu M. Differential immunolocalization of estrogen receptor alpha and beta in rat ovary and uterus. J. Mol. Endocrinol. 22:1999;37-44.
16. Boehnke M., Lange K., Cox D.R. Statistical methods for multipoint radiation hybrid mapping. Am. J. Hum. Genet. 49:1991;1174-1188.
17. Maruyama K., Sugano S. Oligo-capping: A simple method to replace the cap structure of eukaryotic mRNAs with oligoribonucleotides. Gene. 138:1994;171-174.
18. Brown P. C., Silverman J. A. Characterization of the rat mdr2 promoter and its regulation by the transcription factor Sp1. Nucleic Acids Res. 24:1996;3235-3241.
19. Weis L., Reinberg D. Transcription by RNase polymerase II: initiator-directed formation of transcription-competent complexes. FASEB J. 6:1992;3300-3309.
20. Yang Z. Q., Yoshida M. A., Fukuda Y., Kurihara N., Nakamura Y., Inazawa J. Molecular cytogenetic analysis of 17 renal cancer cell lines: Increased copy number at 5q31-33 in cell lines from nonpapillary carcinoma. Jpn. J. Cancer Res. 91:2000;156-163.
21. Walch A. K., Zitzelsberger H. F., Bruch J., Keller G., Angermeier D., Aubele M. M., Mueller J., Stein H., Braselmann H., Siewert J. R., Hofler H., Werner M. Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasis-dysplasia-carcinoma sequence. Am. J. Pathol. 156:2000;555-566.
22. Tada K., Oka M., Tangoku A., Hayashi H., Oga A., Sasaki K. Gains of 8q23-qter and 20q and loss of 11q22-qter in esophageal squamous cell carcinoma associated with lymph node metastasis. Cancer. 88:2000;268-273.
23. Xie W., Duan R., Safe S. Estrogen induces adenosine deaminase gene expression in MCF-7 human breast cancer cells: Role of estrogen receptor-Sp1 interactions. Endocrinology. 140:1999;219-227.
24. Qin C., Singh P., Safe S. Transcriptional activation of insulin-like growth factor-binding protein-4 by 17b-estradiol in MCF-7 cells: Role of estrogen-receptor-Sp1 complexes. Endocrinology. 140:1999;2501-2508.